Enabling stem cell therapies for tissue repair: Current and future challenges

Biotechnology Advances

Volumn 31, Issue 5, 2013, Pages 744-751

  Wong, Victor W ^a   Sorkin, Michael ^a   Gurtner, Geoffrey C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biotechnology; Regenerative medicine; Stem cell; Tissue engineering

Indexed keywords

CLINICAL APPLICATION; CLINICAL THERAPY; FUTURE CHALLENGES; INNOVATIVE APPROACHES; MATERIAL SCIENCE; RANDOMIZED CLINICAL TRIALS; REGENERATIVE MEDICINE; STEM CELL THERAPY;

BIOTECHNOLOGY; GENETIC ENGINEERING; REPAIR; STEM CELLS; TISSUE ENGINEERING;

MOLECULAR BIOLOGY;

BIOTECHNOLOGY; DISEASE TREATMENT; FUTURE PROSPECT; GENETIC ENGINEERING; MEDICINE; OPTIMIZATION;

ANIMAL; BIOTECHNOLOGY; CYTOLOGY; HUMAN; METHODOLOGY; REGENERATIVE MEDICINE; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

ANIMALS; BIOTECHNOLOGY; HUMANS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 84879422279     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.11.006     Document Type: Review

References (89)

1. Arien-Zakay H., Lecht S., Perets A., Roszell B., Lelkes P.I., Lazarovici P. Quantitative assessment of neuronal differentiation in three-dimensional collagen gels using enhanced green fluorescence protein expressing PC12 pheochromocytoma cells. J Mol Neurosci 2009, 37:225-237.
2. Atiyeh B.S., Costagliola M. Cultured epithelial autograft (CEA) in burn treatment: three decades later. Burns 2007, 33:405-413.
3. Baker M. Stem-cell pioneer bows out. Nature 2011, 479:459.
4. Baradez M.O., Marshall D. The use of multidimensional image-based analysis to accurately monitor cell growth in 3D bioreactor culture. PLoS One 2011, 6:e26104.
5. Becerra J., Santos-Ruiz L., Andrades J.A., Mari-Beffa M. The stem cell niche should be a key issue for cell therapy in regenerative medicine. Stem Cell Rev 2011, 7:248-255.
6. Brindley D.A., Reeve B.C., Sahlman W.A., Bonfiglio G.A., Davie N.L., Culme-Seymour E.J., et al. The impact of market volatility on the cell therapy industry. Cell Stem Cell 2011, 9:397-401.
7. Chaikof E., Matthew H., Kohn J., Mikos A., Prestwich G., Yip C. Biomaterials and scaffolds in reparative medicine. Ann N Y Acad Sci 2002, 961:96-105.
8. Chan B., Leong K. Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur Spine J 2008, 17:467-479.
9. Cheng Z., Ou L., Zhou X., Li F., Jia X., Zhang Y., et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 2008, 16:571-579.
10. Cyranoski D. Strange lesions after stem-cell therapy. Nature 2010, 465:997.
11. Cyranoski D. Stem-cell therapy takes off in Texas. Nature 2012, 483:13-14.
12. Dash N., Dash S., Routray P., Mohapatra S., Mohapatra P. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res 2009, 12:359-366.
13. Dawson E., Mapili G., Erickson K., Taqvi S., Roy K. Biomaterials for stem cell differentiation. Adv Drug Deliv Rev 2008, 60:215-228.
14. Dey D., Saxena M., Paranjape A.N., Krishnan V., Giraddi R., Kumar M.V., et al. Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS One 2009, 4:e5329.
15. Einsiedel E.F., Adamson H. Stem cell tourism and future stem cell tourists: policy and ethical implications. Dev World Bioeth 2012, 12:35-44.
16. Ferdowsian H.R., Beck N. Ethical and scientific considerations regarding animal testing and research. PLoS One 2011, 6:e24059.
17. Gandolfi F., Vanelli A., Pennarossa G., Rahaman M., Acocella F., Brevini T.A. Large animal models for cardiac stem cell therapies. Theriogenology 2011, 75:1416-1425.
18. Glotzbach J.P., Januszyk M., Vial I.N., Wong V.W., Gelbard A., Kalisky T., et al. An information theoretic, microfluidic-based single cell analysis permits identification of subpopulations among putatively homogeneous stem cells. PLoS One 2011, 6:e21211.
19. Glotzbach J.P., Wong V.W., Gurtner G.C., Longaker M.T. Regenerative medicine. Curr Probl Surg 2011, 48:148-212.
20. Godara P., McFarland C.D., Nordon R.E. Design of bioreactors for mesenchymal stem cell tissue engineering. J Chem Technol Biotechnol 2008, 83:408-420.
21. Graf T., Stadtfeld M. Heterogeneity of embryonic and adult stem cells. Cell Stem Cell 2008, 3:480-483.
22. Guidelines for the Clinical Treatment of Stem Cells 2008, International Society for Stem Cell Research Task Force.
23. Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration. Nature 2008, 453:314-321.
24. Haupt S., Grützner J., Thier M.-C., Kallweit T., Rath B.H., Laufenberg I., et al. Automated selection and harvesting of pluripotent stem cell colonies. Biotechnol Appl Biochem 2012, 59:77-87.
25. Herberts C.A., Kwa M.S., Hermsen H.P. Risk factors in the development of stem cell therapy. J Transl Med 2011, 9:29.
26. Heuft H.G., Dubiel M., Kingreen D., Oertel J., De Reys S., Rick O., et al. Automated collection of peripheral blood stem cells with the COBE spectra for autotransplantation. Vox Sang 2000, 79:94-99.
27. Hipp J., Atala A. Sources of stem cells for regenerative medicine. Stem Cell Rev 2008, 4:3-11.
28. Ioannidou E. Therapeutic modulation of growth factors and cytokines in regenerative medicine. Curr Pharm Des 2006, 12:2397-2408.
29. Justice B.A., Badr N.A., Felder R.A. 3D cell culture opens new dimensions in cell-based assays. Drug Discov Today 2009, 14:102-107.
30. Kalisky T., Quake S.R. Single-cell genomics. Nat Methods 2011, 8:311-314.
31. Kalisky T., Blainey P., Quake S.R. Genomic analysis at the single-cell level. Annu Rev Genet 2011, 45:431-445.
32. King J.A., Miller W.M. Bioreactor development for stem cell expansion and controlled differentiation. Curr Opin Chem Biol 2007, 11:394-398.
33. Klassen H., Tucker B.A., Liew C.G., La Cour M., Wang H.C. Stem cells in large animal models of retinal and neurological disease. Stem Cells Int 2012, 2012:460504.
34. Kretlow J.D., Jin Y.Q., Liu W., Zhang W.J., Hong T.H., Zhou G., et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 2008, 9:60.
35. Kronenwett R., Martin S., Haas R. The role of cytokines and adhesion molecules for mobilization of peripheral blood stem cells. Stem Cells 2000, 18:320-330.
36. Langer R., Vacanti J.P. Tissue engineering. Science 1993, 260:920-926.
37. Lee K., Silva E.A., Mooney D.J. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 2011, 8:153-170.
38. Levi B., Nelson E.R., Brown K., James A.W., Xu D., Dunlevie R., et al. Differences in osteogenic differentiation of adipose-derived stromal cells from murine, canine, and human sources in vitro and in vivo. Plast Reconstr Surg (1946) 2011, 128:373-386.
39. Levi B., Wan D.C., Glotzbach J.P., Hyun J., Januszyk M., Montoro D., et al. CD105 protein depletion enhances human adipose-derived stromal cell osteogenesis through reduction of transforming growth factor beta1 (TGF-beta1) signaling. J Biol Chem 2011, 286:39497-39509.
40. Li H.W., Sykes M. Emerging concepts in haematopoietic cell transplantation. Nat Rev Immunol 2012, 12:403-416.
41. Li L., Xie T. Stem cell niche: structure and function. Annu Rev Cell Biol 2005, 21:605-631.
42. Li H., Dai K., Tang T., Zhang X., Yan M., Lou J. Bone regeneration by implantation of adipose-derived stromal cells expressing BMP-2. Biochem Biophys Res Commun 2007, 356:836-842.
43. Li W., Ma N., Ong L.L., Nesselmann C., Klopsch C., Ladilov Y., et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 2007, 25:2118-2127.
44. Lim S.Y., Kim Y.S., Ahn Y., Jeong M.H., Hong M.H., Joo S.Y., et al. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc Res 2006, 70:530-542.
45. Ma P.X. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 2008, 60:184-198.
46. Macchiarini P., Jungebluth P., Go T., Asnaghi M.A., Rees L.E., Cogan T.A., et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008, 372:2023-2030.
47. Maddox J.R., Ludlow K.D., Li F., Niyibizi C. Breast and abdominal adipose multipotent mesenchymal stromal cells and stage-specific embryonic antigen 4 expression. Cells Tissues Organs 2012, 196:107-116.
48. Mahaseth H., Kaufman J. Optimizing stem cell collection through CXCR4 antagonists. Front Biosci (Schol Ed) 2012, 4:611-619.
49. Mason C., Dunnill P. A brief definition of regenerative medicine. Regen Med 2008, 3:1-5.
50. Mason C., Brindley D.A., Culme-Seymour E.J., Davie N.L. Cell therapy industry: billion dollar global business with unlimited potential. Regen Med 2011, 6:265-272.
51. Moore K.A., Lemischka I.R. Stem cells and their niches. Science 2006, 311:1880-1885.
52. Muller-Sieburg C.E., Sieburg H.B., Bernitz J.M., Cattarossi G. Stem cell heterogeneity: implications for aging and regenerative medicine. Blood 2012, 119:3900-3907.
53. Narsinh K.H., Sun N., Sanchez-Freire V., Lee A.S., Almeida P., Hu S., et al. Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J Clin Invest 2011, 121:1217-1221.
54. Phinney D.G. Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. J Cell Biochem 2012, 113:2806-2812.
55. Phinney D.G., Kopen G., Isaacson R.L., Prockop D.J. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem 1999, 72:570-585.
56. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
57. Place E.S., George J.H., Williams C.K., Stevens M.M. Synthetic polymer scaffolds for tissue engineering. Chem Soc Rev 2009, 38:1139-1151.
58. Pound P., Ebrahim S., Sandercock P., Bracken M.B., Roberts I. Where is the evidence that animal research benefits humans?. BMJ 2004, 328:514-517.
59. Prockop D.J. "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin Pharmacol Ther 2007, 82:241-243.
60. Qian L., Huang Y., Spencer C.I., Foley A., Vedantham V., Liu L., et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
61. Raaijmakers M.H., Scadden D.T. Divided within: heterogeneity within adult stem cell pools. Cell 2008, 135:1006-1008.
62. Razvi E. Conference scene: trends in the stem cells marketplace - report from Select Biosciences Stem Cells 2012 Conference. Regen Med 2012, 7:291-294.
63. Renner R., Harth W., Simon J.C. Transplantation of chronic wounds with epidermal sheets derived from autologous hair follicles-the Leipzig experience. Int Wound J 2009, 6:226-232.
64. Rigotti G., Marchi A., Galie M., Baroni G., Benati D., Krampera M., et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg (1946) 2007, 119:1409-1422.
65. Rinkevich Y., Lindau P., Ueno H., Longaker M.T., Weissman I.L. Germ-layer and lineage-restricted stem/progenitors regenerate the mouse digit tip. Nature 2011, 476:409-413.
66. Rodrigues C.A., Fernandes T.G., Diogo M.M., da Silva C.L., Cabral J.M. Stem cell cultivation in bioreactors. Biotechnol Adv 2011, 29:815-829.
67. Rustad K.C., Wong V.W., Sorkin M., Glotzbach J.P., Major M.R., Rajadas J., et al. Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold. Biomaterials 2012, 33:80-90.
68. Salgado A.J., Reis R.L., Sousa N.J., Gimble J.M. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 2010, 5:103-110.
69. Sanchez-Freire V., Ebert A.D., Kalisky T., Quake S.R., Wu J.C. Microfluidic single-cell real-time PCR for comparative analysis of gene expression patterns. Nat Protoc 2012, 7:829-838.
70. Scadden D.T. The stem-cell niche as an entity of action. Nature 2006, 441:1075-1079.
71. Schroeder M., Niebruegge S., Werner A., Willbold E., Burg M., Ruediger M., et al. Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control. Biotechnol Bioeng 2005, 92:920-933.
72. Sharma S., Raju R., Sui S., Hu W.S. Stem cell culture engineering - process scale up and beyond. Biotechnol J 2011, 6:1317-1329.
73. Tajbakhsh S. Stem cell: what's in a name?. Nat Reports Stem Cells 2009.
74. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
75. Tang Y.L., Tang Y., Zhang Y.C., Qian K., Shen L., Phillips M.I. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 2005, 46:1339-1350.
76. Tateishi T., Chen G., Ushida T. Biodegradable porous scaffolds for tissue engineering. J Artif Organs 2002, 5:77-83.
77. te Riele H. Recreating stem cells: a novel entrance to the fountain of youth. Cell Stem Cell 2009, 4:279-280.
78. Trobridge G.D., Kiem H.P. Large animal models of hematopoietic stem cell gene therapy. Gene Ther 2010, 17:939-948.
79. Vaculik C., Schuster C., Bauer W., Iram N., Pfisterer K., Kramer G., et al. Human dermis harbors distinct mesenchymal stromal cell subsets. J Invest Dermatol 2012, 132:563-574.
80. van der Sanden B., Dhobb M., Berger F., Wion D. Optimizing stem cell culture. J Cell Biochem 2010, 111:801-807.
81. Voog J., Jones D.L. Stem cells and the niche: a dynamic duo. Cell Stem Cell 2010, 6:103-115.
82. Williams D.F. On the nature of biomaterials. Biomaterials 2009, 30:5897-5909.
83. Wong V.W., Rustad K.C., Galvez M.G., Neofytou E., Glotzbach J.P., Januszyk M., et al. Engineered pullulan-collagen composite dermal hydrogels improve early cutaneous wound healing. Tissue Eng Part A 2011, 17:631-644.
84. Wong V.W., Rustad K.C., Glotzbach J.P., Sorkin M., Inayathullah M., Major M.R., et al. Pullulan hydrogels improve mesenchymal stem cell delivery into high-oxidative-stress wounds. Macromol Biosci 2011, 11:1458-1466.
85. Wright N.A. Stem cell identification-in vivo lineage analysis versus in vitro isolation and clonal expansion. J Pathol 2012, 227:255-266.
86. Wu Y., Chen L., Scott P.G., Tredget E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007, 25:2648-2659.
87. Yamanaka S. A fresh look at iPS cells. Cell 2009, 137:13-17.
88. Yang F., Mei Y., Langer R., Anderson D.G. High throughput optimization of stem cell microenvironments. Comb Chem High Throughput Screen 2009, 12:554-561.
89. Yang F., Cho S.W., Son S.M., Bogatyrev S.R., Singh D., Green J.J., et al. Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci U S A 2010, 107:3317-3322.